Orally active vitamin D for potential chemoprevention of posttransplant malignancy

Cancer Prevention Research

Volumn 5, Issue 10, 2012, Pages 1229-1235

  Obi, Yoshitsugu ^a   Ichimaru, Naotsugu ^a   Hamano, Takayuki ^a   Tomida, Kodo ^b   Matsui, Isao ^a   Fujii, Naohiko ^d   Okumi, Masayoshi ^a   Kaimori, Jun Ya ^a   Yazawa, Koji ^a   Kokado, Yukito ^c   Tsubakihara, Yoshiharu ^a   Nonomura, Norio ^a   Rakugi, Hiromi ^a   Takahara, Shiro ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c Takahashi Clinic   (Japan)

^d Hyogo Prefectural Nishinomiya Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALFACALCIDOL; CALCITRIOL; CREATININE; VITAMIN D;

ADULT; ARTICLE; CANCER INCIDENCE; CHEMOPROPHYLAXIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POSTTRANSPLANT MALIGNANCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY;

ACUTE KIDNEY INJURY; ADULT; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D;

EID: 84867380656     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0218     Document Type: Article

References (47)

1. U.S. Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010. [cited 2011 Mar 15]. Available from: http://www.usrds. org/adr.htm.
2. The Japanese Society for Clinical Renal Transplantation and The Japanese Society for Transplantation. Annual Progress Report from the Japanese Renal Transplant Registry, 2010. Part III: results from 2009 Recipient Follow-up Survey. Isyoku 2010;45:608-20.
3. ANZDATA. Australia and New Zealand Dialysis and Transplant Registry Annual Report. [cited 2011 Mar 15]. Available from: http://www.anzdata.org.au/ v1/annual-reports-download.html.
4. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007;7:941-8. (Pubitemid 46481211)
5. The Japanese Society for Clinical Renal Transplantation and The Japanese Society for Transplantation. Annual Progress Report from the Japanese Renal Transplant Registry, 2007. Part III: results from 2006 Recipient Follow-up Survey. Isyoku 2007;42:545-57.
6. The Japanese Society for Clinical Renal Transplantation and The Japanese Society for Transplantation. Annual Progress Report from the Japanese Renal Transplant Registry, 2005. Part III: results from 2003 Recipient Follow-up Survey. Isyoku 2003;40:358-68.
7. Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant 2001;16:1545-9. (Pubitemid 32750442)
8. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010;77:299-311.
9. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 2007;22 Suppl 1:i4-10.
10. Chapman JR, Campistol JM. Malignancy in renal transplantation: opportunities with proliferation signal inhibitors. Nephrol Dial Transplant 2007;22:i1-3. (Pubitemid 47073737)
11. Ewers B, Gasbjerg A, Moelgaard C, Frederiksen AM, Marckmann P. Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr 2008;87:431-7. (Pubitemid 351226081)
12. Stavroulopoulos A, Cassidy MJ, Porter CJ, Hosking DJ, Roe SD. Vitamin Dstatus in renal transplant recipients. Am J Transplant 2007;7:2546-52. (Pubitemid 47561620)
13. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 2010;9:941-55.
14. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010;9:709-15.
15. Courbebaisse M, Souberbielle JC, Thervet E. Potential nonclassical effects of vitamin D in transplant recipients. Transplantation 2010;89:131-7.
16. Mohr S, Garland C, Gorham E, Grant W, Garland F. Could ultraviolet B irradiance and vitamin D be associated with lower incidence rates of lung cancer? J Epidemiol Community Health 2008;62:69-74.
17. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007;25:479-85. (Pubitemid 350002952)
18. Ducloux D, Courivaud C, Bamoulid J, Kazory A, Dumoulin G, Chalopin JM. Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 2008;85:1755-9.
19. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D- 1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005;97:103-9. (Pubitemid 41546219)
20. Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010;16:1-9.
21. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007;7:684-700. (Pubitemid 47327412)
22. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011;51:311-36.
23. Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 2011; 94:1144-9.
24. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91. (Pubitemid 46890428)
25. Naves-Diaz M, Alvarez-Hernandez D, Passlick-Deetjen J, Guinsburg A, Marelli C, Rodriguez-Puyol D, et al. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int 2008;74:1070-8.
26. Japan Meteorological Agency. Mean daily cumulative dose of ultra-violet- B radiation by month. [cited 2011 Dec 12]. Available from: http://www.data. kishou.go.jp/obs-env/uvhp/uvb-monthave-tsu.html.
27. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 1973; 4:643-6.
28. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007;11:41-50. (Pubitemid 46474965)
29. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 2009;42:1549-56.
30. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:1503-10. (Pubitemid 26035533)
31. Agostino RBD. Tutorial in biostatistics propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;2281:2265-81.
32. Rosenbaum PR. Optimal Matching for Observational Studies. J Am Stat Assoc 1989;84:1024-32.
33. Hirano K, Imbens GW. Estimation of causal effects using propensity score weighting: an application to data on right heart catheterization. Health Serv Outcomes Res Methodol 2001;2:259-78.
34. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003;42 Suppl 3:S1-202.
35. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, et al. Cancer incidence before and after kidney transplantation. JAMA 2006;296:2823-31. (Pubitemid 44969182)
36. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-13. (Pubitemid 38745589)
37. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000;355:1886-7. (Pubitemid 30311885)
38. Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer-ready for prime time? N Engl J Med 2011;364:1385-7.
39. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:31-8. (Pubitemid 44967731)
40. Gallieni M, Kamimura S, Ahmed A, Bravo E, Delmez J, Slatopolsky E, et al. Kinetics of monocyte 1 alpha-hydroxylase in renal failure. Am J Physiol 1995;268:F746-53.
41. Imao T, Ichimaru N, Takahara S, Kokado Y, Okumi M, Imamura R, et al. Risk factors for malignancy in Japanese renal transplant recipients. Cancer 2007;109:2109-15. (Pubitemid 46744207)
42. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891-901.
43. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000;342:1027-38. (Pubitemid 30180651)
44. Blomberg Jensen M, Andersen CB, Nielsen JE, Bagi P, Jorgensen A, Juul A, et al. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer. J Steroid Biochem Mol Biol 2010; 121:376-82.
45. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:2958-69.
46. Gissel T, Rejnmark L, Mosekilde L, Vestergaard P. Intake of vitamin D and risk of breast cancer - a meta-analysis. J Steroid Biochem Mol Biol 2008;111:195-9.
47. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010;121:469-77.